Daniel Lovrić
Daniel Lovrić
Explore linked clinical trials.1 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CONTinuous Infusion Versus Intermittent Dosing of ceftaZidime/AVIbactam in Critically Ill Patients | Bacterial Infections and Mycoses, Critical Illness, Disease Attributes, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pseudomonas infection, bacterial infectious disease, gram-negative bacterial infections | Not yet recruiting | Phase 4 | 2025-04-22 | NCT06811727 |